The effect of increased positive radial acceleration upon perceptual speed ability.

A. Comrey,A. A. Canfield,R. C. Wilson,W. S. Zimmerman

1951-02-01

Abstract:

What problem does this paper attempt to address?

Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in China.

Guo-qing Wang,D. Lin,J. Hou,H. Feng,Y. Qiao,Yu-tong He,Zhi-feng Chen,Shao-Sen Li,Z. Dong,Xinqing Li,Wenqiang Wei,C. Abnet,Cui-Lan Guo

DOI: https://doi.org/10.1200/JCO.2014.58.0423

IF: 45.3

2015-05-04

Journal of Clinical Oncology

Abstract:PURPOSE There are no global screening recommendations for esophageal squamous cell carcinoma (ESCC). Endoscopic screening has been investigated in areas of high incidence in China since the 1970s. This study aimed to evaluate whether an endoscopic screening and intervention program could reduce mortality caused by ESCC. METHODS Residents age 40 to 69 years were recruited from communities with high rates of ESCC. Fourteen villages were selected as the intervention communities. Ten villages not geographically adjacent to intervention villages were selected for comparison. Participants in the intervention group were screened once by endoscopy with Lugol's iodine staining, and those with dysplasia or occult cancer were treated. All intervention participants and a sample consisting of one tenth of the control group completed questionnaires. We compared cumulative ESCC incidence and mortality between the two groups. RESULTS Three thousand three hundred nineteen volunteers (48.62%) from an eligible population of 6,827 were screened in the intervention group. Seven hundred ninety-seven volunteers from an eligible population of 6,200 in the control group were interviewed. Six hundred fifty-two incident and 542 fatal ESCCs were identified during the 10-year follow-up. A reduction in cumulative mortality in the intervention group versus the control group was apparent (3.35% v 5.05%, respectively; P < .001). Furthermore, the intervention group had a significantly lower cumulative incidence of ESCC versus the control group (4.17% v 5.92%, respectively; P < .001). CONCLUSION We showed that endoscopic screening and intervention significantly reduced mortality caused by esophageal cancer. Detection and treatment of preneoplastic lesions also led to a reduction in the incidence of this highly fatal cancer.

Medicine
Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized Trial

Mengfei Liu,Wenlei Yang,Chuanhai Guo,Zhen Liu,Fenglei Li,Anxiang Liu,Haijun Yang,Lin Shen,Qi Wu,Liping Duan,Hui Wang,Hongrui Tian,Chao Shi,Yaqi Pan,Ying Liu,Fangfang Liu,Noel S Weiss,Hong Cai,Zhonghu He,Yang Ke

DOI: https://doi.org/10.1200/JCO.23.01284

2024-05-10

Abstract:Purpose: To evaluate the effectiveness of endoscopic screening against incidence of and mortality from esophageal squamous cell carcinoma (ESCC). Methods: From January 2012 to September 2016, we conducted a community-based cluster randomized controlled trial involving permanent residents age 45-69 years in a high-risk region for ESCC in northern China. A total of 668 targeted villages were randomly assigned in a 1:1 ratio to the screening group (offered Lugol's chromoendoscopy) or control group (no screening). Intention-to-treat and per-protocol analyses were performed to compare esophageal cancer (EC) incidence and mortality between the two groups. The per-protocol analysis adjusted for nonadherence to the screening procedure. Results: A total of 33,847 participants were included in the analysis: 17,104 in the screening group, 15,165 (88.7%) of whom underwent screening, and 16,743 in the control group. During a maximum follow-up of 9 years, EC incidence in the screening and control groups were 60.9 and 72.5 per 100,000 person-years, respectively; mortality in the screening and control groups were 29.7 and 32.4 per 100,000 person-years, respectively. Compared with the control group, the incidence and mortality of the screening group reduced by 19% (adjusted hazard ratio [aHR], 0.81 [95% CI, 0.60 to 1.09]) and 18% (aHR, 0.82 [95% CI, 0.53 to 1.26]), respectively, in the intention-to-treat analysis; and by 22% (aHR, 0.78 [95% CI, 0.56 to 1.10]) and 21% (aHR, 0.79 [95% CI, 0.49 to 1.30]), respectively, in the per-protocol analysis. Conclusion: With a 9-year follow-up, our trial suggests that chromoendoscopic screening induces modest reductions in EC incidence and mortality. A more efficient strategy for EC screening and subsequent patient management should be established to guarantee the effectiveness of endoscopic screening.
Effectiveness of Intensive Endoscopic Screening for Esophageal Cancer in China: A Community-Based Study

Mengfei Liu,Zhonghu He,Chuanhai Guo,Ruiping Xu,Fenglei Li,Tao Ning,Yaqi Pan,Yong Li,Huirong Ding,Li Zheng,Yue Zhou,Xiuyun Tian,Wenjun Yang,Xueqian Wang,Fang Lu,Yanyan Zhang,Yiqiang Zhao,Fangcen Guo,Ke Chen,Lei Gao,Min Sun,Ying Liu,Fangfang Liu,Dong Hang,Na Shen,Jingjing Li,Zhongyao Xu,Qiyan Wang,Chanyuan Zhang,Amir Abliz,Qiuju Deng,Xiang Li,Zhen Liu,Chaoting Zhang,Wenqing Yuan,Hui Wang,Noel S. Weiss,Hong Cai,Yang Ke

DOI: https://doi.org/10.1093/aje/kwy291

2018-01-01

American Journal of Epidemiology

Abstract:Evidence is required to evaluate the effectiveness of population-level endoscopic screening for esophageal cancer (EC). In this study, 5,632 permanent residents aged 25-65 years from 6 villages in Hua County, Henan Province, China, were defined as the screening cohort and were offered intensive endoscopic screening. Residents of all 914 remaining villages in Hua County were included as the control cohort, and age-sex standardization was used to calculate the expected numbers of EC and upper gastrointestinal (GI) tract cancer cases and deaths in the screening cohort. The effectiveness of screening was assessed by comparing observed numbers of cases and deaths with expected numbers after 9-year follow-up of these screened subjects (2007-2016). In the screening cohort, 23 upper GI cancers (including 16 ECs) and 10 upper GI cancer deaths (including 5 EC deaths) were identified, and 47% (standardized incidence ratio = 0.53, 95% confidence interval (CI): 0.33, 0.87) and 66% (standardized mortality ratio = 0.34, 95% CI: 0.14, 0.81) reductions in cumulative EC incidence and mortality were found. For upper GI cancers, incidence and mortality were lowered by 43% (standardized incidence ratio = 0.57, 95% CI: 0.38, 0.86) and 53% (standardized mortality ratio = 0.47, 95% CI: 0.25, 0.88), respectively. This study showed that upper GI tract endoscopy is an effective population-level screening test for EC in high-risk regions.
Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study

Ru Chen,Yong Liu,Guohui Song,Bianyun Li,Deli Zhao,Zhaolai Hua,Xinzheng Wang,Jun Li,Changqing Hao,Liwei Zhang,Shuzheng Liu,Jialin Wang,Jinyi Zhou,Yongzhen Zhang,Bo Li,Yanyan Li,Xiang Feng,Lin Li,Zhiwei Dong,Wenqiang Wei,Guiqi Wang

DOI: https://doi.org/10.1136/gutjnl-2019-320200

IF: 24.5

2020-04-02

Gut

Abstract:Objectives To estimate the effectiveness of endoscopic screening programme in reducing incidence and mortality of upper gastrointestinal cancer in high risks areas of China. Design This multicentre population-based cohort study was conducted in six areas in China from 2005 to 2015. All permanent residents aged 40 to 69 years were identified as target subjects. We refer to those who were invited for screening collectively as the invited group. Of these, we classify those who were invited and undertook endoscopic screening as the screened group and those who were invited but did not accept screening as the non-screened group. Target subjects who were not invited to the screening were assigned to the control group. The effectiveness of the endoscopic screening and screening programme were evaluated by comparing reductions in incidence and mortality from upper gastrointestinal cancer in the screened and invited group with control group. Results Our cohort analysis included 637 500 people: 299 483 in the control group and 338 017 in the invited to screening group, 113 340 (33.53%) of whom were screened eventually. Compared with subjects in the control group, upper gastrointestinal cancer incidence and mortality decreased by 23% (relative risk (RR)=0.77, 95% CI 0.74 to 0.81) and 57% (RR=0.43, 95% CI 0.40 to 0.47) in the screened group, respectively, and by 14% (RR=0.86, 95% CI 0.84 to 0.89) and 31% (RR=0.69, 95% CI 0.66 to 0.72) in the invited group, respectively. Conclusion Among individuals aged 40 to 69 years in high risk areas of upper gastrointestinal cancer, one-time endoscopic screening programme was associated with a significant decrease in upper gastrointestinal cancer incidence and mortality.

gastroenterology & hepatology
An initial screening strategy based on epidemiologic information in esophageal cancer screening: a prospective evaluation in a community-based cancer screening cohort in rural China

Wanqing Chen,He Li,Rongshou Zheng,Jiansong Ren,Jufang Shi,Maomao Cao,Dianqin Sun,Xibin Sun,Xiaoqin Cao,Jinyi Zhou,Pengfei Luo,Jialin Wang,Hengmin Ma,Tiantang Shao,Chunling Zhao,Shilin He,Daokuan Sun,Yuluan Xu,Pengli Wu,Hongmei Zeng,Jiang Li,Jie He

DOI: https://doi.org/10.1016/j.gie.2020.05.052

IF: 10.396

2021-01-01

Gastrointestinal Endoscopy

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background and Aims</h3><p>In China, regional organized esophageal cancer screening programs have been implemented since 2005. However, the implementation of these screening programs is still facing some urgent challenges, especially concerning identifying high-risk individuals. This study aimed to evaluate the risk stratification potential of the current initial assessment strategy used in a mass esophageal squamous cell carcinoma (ESCC) screening program in China.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials</h3><p>A total of 43,875 participants without prior cancer history enrolled in a mass ESCC screening program in China from 2007 to 2010 who had initial assessment results were included in this study and were followed until December 31, 2015. Eight potential risk factors for ESCC were evaluated in the initial assessment strategy. A comprehensive evaluation of the association of the initial assessment results with ESCC risk was performed by propensity score matching and Cox regression analysis.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>During a median follow-up of 5.5 years, 272 individuals developed ESCC. The high-risk population assessed at baseline had a higher risk of ESCC than the non–high-risk population, with a hazard ratio (HR) of 3.11 (95% confidence interval (CI), 2.33-4.14) after adjustment for sex, age, education level, income level, and body mass index. Additionally, the initial assessment results of the high-risk population were significantly associated with the risk of all esophageal cancers (HR, 3.30; 95% CI, 2.51-4.33) and upper gastrointestinal cancers (HR, 3.03; 95% CI, 2.43-3.76).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>The initial screening tool in a mass ESCC screening program in China, consisting of eight accessible variables in epidemiological surveys, could be helpful for the selection of asymptomatic individuals for priority ESCC screening.</p>

gastroenterology & hepatology
Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial

Zhonghu He,Zhen Liu,Mengfei Liu,Chuanhai Guo,Ruiping Xu,Fenglei Li,Anxiang Liu,Haijun Yang,Lin Shen,Qi Wu,Liping Duan,Xiang Li,Chaoting Zhang,Yaqi Pan,Hong Cai,Yang Ke

DOI: https://doi.org/10.1136/gutjnl-2017-315520

IF: 24.5

2018-01-06

Gut

Abstract:Objective Description of the design and preliminary results of baseline recruitment and screening in the endoscopic screening for esophageal cancer in China (ESECC), the first randomised controlled trial (RCT) assessing efficacy and cost-effectiveness of endoscopic screening for esophageal squamous cell carcinoma (ESCC). Design ESECC trial is a cluster RCT, and 668 villages in rural Hua County, Henan Province, a high-incidence area of ESCC in China, were randomised into two arms at a ratio of 1:1. Screening arm participants were screened by Lugol chromoendoscopy; no screening was performed in the control arm. ESCC-specific and all-cause mortality, incidence of advanced ESCC and cost-effectiveness of screening will be evaluated in the next 10-year follow-up. Here, we report the performance of baseline recruitment and randomisation, prevalence of upper GI lesions and risk factors for ESCC. Results A total of 17 151 and 16 797 participants were enrolled in screening and control arms from January 2012 to September 2016. The truncated prevalence (aged 45–69 years) of oesophageal and overall upper GI high-grade lesions was 744.0/100 000 and 902.0/100 000. 69.9% of the 113 patients with high-grade oesophageal lesions were of early stage. Risk factors for severe oesophageal dysplasia and more severe lesions in this population included higher age, family history of ESCC, lower body mass index, eating rapidly and frequent ingestion of leftovers. Conclusion This ESECC trial met the predesigned recruitment and randomisation requirements. Age, family history, undernutrition and unhealthy dietary habits increased the risk for high-grade oesophageal lesions in this high-risk population. Trail registration number NCT01688908; Pre-results .

gastroenterology & hepatology
Modeling the Cost-effectiveness of Esophageal Cancer Screening in China

Li Yuanyuan,Du Lingbin,Wang Youqing,Gu Yuxuan,Zhen Xuemei,Hu Xiaoqian,Sun Xueshan,Dong Hengjin

DOI: https://doi.org/10.1186/s12962-020-00230-y

2020-01-01

Cost Effectiveness and Resource Allocation

Abstract:Background : This study aimed to examine the cost-effectiveness of one-time standard endoscopic screening with Lugol’s iodine staining for esophageal cancer (EC) in China. Methods : A Markov decision analysis model with eleven states was built. Individuals aged 40 to 69 years were classified into six age groups in five-year intervals. Three different strategies were adopted for each cohort: (1) no screening; (2) one-time endoscopic screening with Lugol’s iodine staining with an annual follow-up for low-grade intraepithelial neoplasia (LGIN); and (3) one-time endoscopic screening with Lugol’s iodine staining without follow-up. Quality-adjusted life-years (QALYs) indicated the effectiveness of the model. The incremental cost-effectiveness ratio (ICER) was used as the evaluation indicator. Sensitivity analysis was performed to assess the robustness of the model. Results : One-time screening with follow-up was the undominated strategy for individuals aged 40-44 and 45-49 years, which saved USD 10,942.57 and USD 6,611.73 per QALY gained compared to nonscreening strategy . For those aged 50-69 years, the nonscreening scenarios were undominated. One-time screening without follow-up was the extended dominated strategy. Compared to screening strategies without follow-up, all the screening strategies with follow-up were more cost-effective, with the ICER increasing from 299.57 USD/QALY for individuals aged 40-44 years to 1617.72 USD/QALY for individuals aged 65-69 years. Probabilistic sensitivity analysis (PSA) supported the results of the base case analysis. Conclusions : One-time EC screening with follow-up targeting individuals aged 40-49 years was the most cost-effective strategy.
[Cost-Effectiveness Analysis of Esophageal Cancer Once-in-a-lifetime Endoscopic Screening in High-Risk Areas of Rural China].

Hao Feng,Guohui Song,Juan Yang,Changqing Hao,Meng Wang,Bianyun Li,Deli Zhao,Zhicai Liu,Wenqiang Wei,Youlin Qiao

DOI: https://doi.org/10.3760/cma.j.issn.0253-3766.2015.06.017

2015-01-01

Abstract:OBJECTIVE:To estimate the cost-effectiveness of esophageal cancer endoscopic screening once-in-a-lifetime and to predict the optimal screening age for people in high-risk areas of rural China.METHODS:A Markov model was constructed to predict and compare the effect of four esophageal cancer endoscopic screening modalities which varied with different screening ages. Long-term epidemiological effectiveness and cost-effectiveness were predicted by simulation of the model.RESULTS:Compared with the control group, strategies starting at 40, 45, 50 and 55 year-old had saved life-years of 629.51, 769.88, 738.98 and 533.21 years per 100 000 people, respectively, of which the strategy starting at 45 year-old saved the maximum life years. All strategies were cost-effective and starting at 40 year-old cost the most per life-year saved. Among all alternatives, strategies starting age at 45 year-old and 50 year-old were incremental cost-effective, and the incremental cost-effective ratios were 34 962.87 and 3 346.43 RMB per life year saved, respectively.CONCLUSIONS:The strategy starting at 40 year-old implemented at present and other strategies were cost-effective in high-risk areas of rural China. However, the 45-year-old group is more aligned with the principle of cost-effectiveness. Considering the cost-effectiveness of different strategies and social economic status, 45 year-old is regarded as the optimal starting age of esophageal cancer once-in-a-lifetime endoscopic screening and is recommended in areas lacking health resources. The strategy of starting age at 40 year-old which could obtain better screening effects would be preferable in wealthy regions.
Massive Endoscopic Screening for Esophageal and Gastric Cancers in a High-Risk Area of China

Xianzhi Zheng,Xuhua Mao,Kun Xu,Lingshuang Lu,Xianzhen Peng,Min Wang,Guisheng Xu,Zhaolai Hua,Jianping Wang,Hengchuan Xue,Jianming Wang,Cheng Lu

DOI: https://doi.org/10.1371/journal.pone.0145097

IF: 3.7

2015-01-01

PLoS ONE

Abstract:This study aims to describe the findings from a massive endoscopic screening program in a high-risk area of China and to evaluate the prognosis of patients diagnosed through endoscopic screening compared with those diagnosed at usual hospital visits because of illness.In 2006, an early detection and treatment program was initiated in Yangzhong county, China. Local residents aged 40-69 years were eligible for free endoscopic screening. Endoscopic examination was performed with Lugol's iodine staining, followed by biopsies. Patients diagnosed with esophageal or gastric cancer were referred for treatment and followed to assess their long-term survival status.From 2006 through 2012, we screened 12453 participants, including 5334 (42.8%) men and 7119 (57.2%) women. The average age was 52.8 ± 8.0 years. We detected 166 patients with upper digestive tract cancers, including 106 cancers in the esophagus (detection rate: 0.85%) and 60 cancers in the stomach (detection rate: 0.48%). Of these patients, 98.11% with esophageal cancer and 100% with gastric cancer were defined as at the early stage. In the process of follow-up, 17 patients died from cancer-related causes, and the median survival time was greater than 85 months. The overall survival rates for 1, 3 and 5 years were 98.0%, 90.0% and 89.0%, respectively. A significant positive effect was observed for the long-term survival of patients diagnosed through massive endoscopic screening.In a high-risk population, massive endoscopic screening can identify early stage carcinoma of esophageal and gastric cancers and improve patients' prognosis through early detection and treatment.
Beneficial Effects of Endoscopic Screening on Gastric Cancer and Optimal Screening Interval: a Population-Based Study.

Wen-Qing Li,Xiang-Xiang Qin,Zhe-Xuan Li,Le-Hua Wang,Zong-Chao Liu,Xiao-Han Fan,Li-Hui Zhang,Yi Li,Xiu-Zhen Wu,Jun-Ling Ma,Yang Zhang,Lan-Fu Zhang,Ming Li,Tong Zhou,Jing-Ying Zhang,Jian-Xi Wang,Wei-Dong Liu,Wei-Cheng You,Kai-Feng Pan

DOI: https://doi.org/10.1055/a-1728-5673

2021-01-01

Endoscopy

Abstract:Background The effectiveness of endoscopic screening on gastric cancer has not been widely investigated in China and the screening interval of repeated screening has not been determined. Methods In a population-based prospective study, we included 375,800 individuals, 14,670 of whom underwent endoscopic screening (2012-2018). We assessed the associations between endoscopic screening and risk of incident gastric cancer and gastric cancer-specific mortality, and examined changes in overall survival and disease-specific survival following screening. The optimal screening interval for repeated endoscopy for early detection of gastric cancer was explored. Results Ever receiving endoscopic screening significantly decreased the risk of invasive gastric cancer (age- and sex-adjusted relative risk [RR] 0.69, 95 % confidence interval [CI] 0.52-0.92) and gastric cancer-specific mortality (RR 0.33, 95 %CI 0.20-0.56), particularly for noncardia gastric cancer. Repeated screening strengthened the beneficial effect on invasive gastric cancer-specific mortality of one-time screening. Among invasive gastric cancers, screening-detected individuals had significantly better overall survival (RR 0.18, 95 %CI 0.13-0.25) and disease-specific survival (RR 0.18, 95 %CI 0.13-0.25) than unscreened individuals, particularly for those receiving repeated endoscopy. For individuals with intestinal metaplasia or low grade intraepithelial neoplasia, repeated endoscopy at an interval of < 2 years, particularly within 1 year, significantly enhanced the detection of early gastric cancer, compared with repeated screening after 2 years ( P-trend = 0.02). Conclusion Endoscopic screening prevented gastric cancer occurrence and death, and improved its prognosis in a population-based study. Repeated endoscopy enhanced the effectiveness. Screening interval should be based on gastric lesion severity.
Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled Trial

Fuxiao Li,Xiang Li,Chuanhai Guo,Ruiping Xu,Fenglei Li,Yaqi Pan,Mengfei Liu,Zhen Liu,Chao Shi,Hui Wang,Minmin Wang,Hongrui Tian,Fangfang Liu,Ying Liu,Jingjing Li,Hong Cai,Li Yang,Zhonghu He,Yang Ke

DOI: https://doi.org/10.1007/s40273-019-00766-9

2019-01-01

PharmacoEconomics

Abstract:Background and ObjectivePopulation-level endoscopic screening for esophageal cancer has been conducted in China for years. In this study, we aim to provide an updated and precise cost estimation for esophageal cancer screening based on a randomized controlled trial in a high-risk area in China.MethodsWe estimated the cost of esophageal cancer screening with chromoendoscopy using a micro-costing approach based on primary data of the ESECC (Endoscopic Screening for Esophageal Cancer in China) randomized controlled trial (NCT01688908) from a health sector perspective. Unit costs and quantities of resources were collected to obtain annual screening costs. The screening project was then theoretically expanded to a 10-year period to explore long-term trends of costs. Costs were adjusted to US dollars for the year 2018.ResultsIn the ESECC trial, screening cost per endoscopy with a valid pathologic diagnosis was $196, accounting for 3.82% of the gross domestic product per capita in Hua County, and the costs for detecting one esophageal cancer and one early-stage esophageal cancer were $26,347 and $37,687, respectively. In conventional screening in which protocol-driven costs were excluded, costs as above were $134, $18,074, and $25,853. The cost for detecting one gastric cardia cancer or stomach cancer was nine times higher than detecting one esophageal cancer owing to low prevalences of the two cancers. In a simulated 10-year screening project, annual cost decreased notably over time.ConclusionsDespite the relatively low absolute cost, population-level endoscopic screening will still be a heavy burden on local government considering the socioeconomic conditions. Long-lasting programs would be less costly and population-level screening would make little sense in non-high-risk regions.
PP64 Economic Evaluation for Esophageal Cancer Screening in China

Yuanyuan Li,Lingbin Du,Xiaoqian Hu,Shuyan Gu,Xuemei Zhen,Yuxuan Gu,Hengjin Dong

DOI: https://doi.org/10.1017/s0266462319002149

2019-01-01

International Journal of Technology Assessment in Health Care

Abstract:IntroductionThe aim of the study was to estimate the cost-effectiveness of esophageal cancer (EC) screening compared to non-screening in China.MethodsA Markov model was conducted that followed the history of EC. Screening strategies targeted a population aged 40-69 years, classified into six age groups. Each age group had three cohorts: screening without follow-up, screening with yearly follow-up for low-grade intraepithelial neoplasia (LGIN), and non-screening. Life years (LYs) and quality-adjusted life years (QALYs) presented the effectiveness and utility. The incremental cost-effectiveness ratio (ICER) and incremental cost-utility ratio (ICUR) were evaluating indicators. Eighteen cohorts from 100,000 hypothetical individuals were used to run the model, until aged 79 years or death. Costs were changed into USD using the purchasing power parity of 3.506 in 2017. The willingness-to-pay was set as three times the gross domestic product per capita (USD 51,340.6) in 2017. A sensitivity analysis was introduced to assess model robustness.ResultsScreening with follow-up compared to non-screening, ages 40-44, 45-49, and 50-54 years, showed cost-effectiveness, with one LY gained costing USD 6,875.0, USD 9,204.6, and USD 25,278.6, respectively. Ages 40-44 and 45-49 years explained cost-utility, with ICURs of USD 6,709.4/QALY and USD 13,991.4/QALY, respectively. Screening without follow-up compared to non-screening, ages 40-54 years, addressed cost-effectiveness, with one LY gained costing USD 6,934.8, USD 9,760.0, and USD 35,126.0 in ages 40-44, 45-49, and 50-54 years, respectively; the 40-44 years age group demonstrated cost-utility with an ICUR of USD 8,512.3/QALY. Screening with follow-up compared to screening without follow-up, all ages, explained cost-effectiveness and cost-utility. The probabilistic sensitivity analysis supported the outcome of the base cohort analysis.ConclusionsCompared to non-screening, screening with follow-up targeting ages 40-54 years was highly recommended with the ICER as the evaluated indicator, whereas it targeting ages 40-49 years was suggested with the ICUR as indicator.
Effectiveness of Risk-Adapted Upper Gastrointestinal Cancer Screening in China: Prospective Cohort Study

Youqing Wang,Juan Zhu,Huizhang Li,Le Wang,Chen Zhu,Xue Li,Shi Wang,Lingbin Du

DOI: https://doi.org/10.2196/62864

2024-10-12

JMIR Public Health and Surveillance

Abstract:Background: Previous studies have proved the efficacy of endoscopic screening in rural areas. Nevertheless, evidence regarding the efficacy of sequential screening strategies in resource-rich regions is currently lacking. Objective: The objective was to validate the efficacy of risk-adapted sequential screening strategies in upper gastrointestinal cancer(UGC) prevention and control, and assess its potential to lower mortality rates. Methods: A prospective cohort study based on population was conducted to recruit individuals from four cities in China from 2013-2019. Those identified as having a high risk of UGC according to a validated risk-score model were advised to undergo endoscopy tests. Outcomes were tracked until June 2021. Incidence of UGC, UGC-related mortality, and all-cause mortality were evaluated between the screened and non-screened cohorts. Results: The study included 153,079 participants at baseline. Among them, 74.4% were evaluated as low-risk for UGC, while 25.6% were deemed high-risk and invited for endoscopy tests, with a compliance rate of 24.6%. Over a median follow-up of 6.05 years, 622 UGC cases, 180 UGC deaths, and 1958 all-cause death cases were traced. The screened cohort exhibited the highest cumulative incidence of UGC(119.2 per 100,000 person-years), followed by the non-screened and low-risk cohorts. Obvious reductions in both all-cause mortality and UGC mortality were observed among those who undertook screening(153.7 and 4.7 per 100,000 person-years) and non-screened group(245.3 and 27.0 per 100,000 person-years). The screening population showed a significant 36% and 82% reduction in both all-cause mortality(HR 0.64, 95% CI 0.49-0.83) and UGC mortality(0.18, 0.04-0.74) compared to the non-screened group. Conclusions: Our study suggests the significance of risk-adapted UGC screening in reducing both all-cause mortality and UGC mortality, particularly among high-risk individuals, indicating its effectiveness in UGC prevention and management.

public, environmental & occupational health
Correction: Effectiveness of Risk-Adapted Upper Gastrointestinal Cancer Screening in China: Prospective Cohort Study

Youqing Wang,Juan Zhu,Huizhang Li,Le Wang,Chen Zhu,Xue Li,Shi Wang,Lingbin Du

DOI: https://doi.org/10.2196/preprints.67642

2024-11-07

JMIR Public Health and Surveillance

Abstract:Previous studies have proved the effectiveness of endoscopic screening in rural areas; however, long-term, high-quality evidence regarding the effectiveness of risk-adapted upper gastrointestinal cancer (UGC) sequential screening strategies in resource-rich regions is currently lacking. Previous studies have proved the effectiveness of endoscopic screening in rural areas; however, long-term, high-quality evidence regarding the effectiveness of risk-adapted upper gastrointestinal cancer (UGC) sequential screening strategies in resource-rich regions is currently lacking. Based on the Cancer Screening Program in Urban China, a prospective, large-scale cohort study based on population was conducted to recruit individuals from 4 cities in China from 2013‐2019. Those identified as having a high risk of UGC according to a validated risk-score model were advised to undergo endoscopy tests. Follow-up outcomes were tracked until June 2021. Incidence of UGC, UGC-related mortality, and all-cause mortality were evaluated between the screened and nonscreened cohorts. The study included 153,079 participants at baseline. In total, 113,916 (74.42%) of the participants were designated as low risk of UGC. The remaining 39,163 (25.68%) participants were deemed to be at high risk of UGC and were offered gastroscopy tests. Among the high-risk participants, 9627 (compliance rate 24.6%) adhered to the gastroscopy tests. Over a median follow-up of 6.05 (IQR 3.06‐7.06) years, 622 UGC cases, 180 UGC deaths, and 1958 all-cause death cases were traced. The screened cohort exhibited the highest cumulative incidence of UGC (119.2 per 100,000 person-years), followed by the nonscreened and low-risk cohorts. Obvious reductions in both all-cause mortality and UGC mortality were observed between those who undertook screening (153.7 and 4.7 per 100,000 person-years, respectively) and the nonscreened group (245.3 and 27 per 100,000 person-years, respectively). The screening population showed a significant 36% and 82% reduction in both all-cause mortality (hazard ratio [HR] 0.64, 95% CI 0.49‐0.83, P.05). Our study suggests the significance of one-off risk-adapted UGC screening in reducing both all-cause mortality and UGC mortality, particularly among high-risk individuals, indicating its effectiveness in UGC prevention and management.

public, environmental & occupational health
Optimal starting age of endoscopic screening for esophageal cancer in China: A multicenter prospective cohort study

Ru Chen,Lizhou Dou,Jiachen Zhou,Guohui Song,Bianyun Li,Deli Zhao,Zhaolai Hua,Xinzheng Wang,Jun Li,Changqing Hao,Yanyan Li,Xiang Feng,Lin Li,Wenqiang Wei,Guiqi Wang

DOI: https://doi.org/10.1002/cam4.5727

IF: 4.711

2023-04-09

Cancer Medicine

Abstract:Compared with the unscreened group, initiation of screening after 50 years was associated with a greater reduction in cumulative incidence and mortality in 10 years follow‐up compared with initiation before 50 years. Background Although endoscopic screening for esophageal cancer has been performed in high‐risk areas in China for decades, there is limited and inconsistent evidence regarding the starting age for individuals participating in screening. The aim of this study is to investigate the optimal starting age of esophageal cancer screening. Methods This study is based on a multicenter prospective cohort consisting 338,017 permanent residents aged 40–69 years in six high‐risk areas of esophageal cancer in China. The participation rate, detection rate, hazard ratios (HRs), cumulative incidence and mortality and number needed to screen (NNS) were calculated in each age group. Screening burden, benefit and risk were compared among screening strategies with different initiation ages to explore the optimal starting age for population‐based screening in high‐risk areas. Results Individuals aged 50–69 had a higher participation rate, a higher detection rate and improved screening effectiveness than those aged 40–49. The endoscopic screening had no significant effect on reducing the incidence of esophageal cancer in individuals under 55 and mortality in individuals under 45. Increasing the starting age to 50 years reduced the screening demand and NNS by 40% and 55%, and resulted in 12% of detectable positive cases, 16% of preventable incident cases, and 14% of preventable deaths being missed. Conclusions Postponing the starting age of endoscopic screening to 50 years might yield a more‐favorable balance between screening benefit and burden in high‐ risk areas with limited resources.

oncology
Cost-effectiveness of precision screening for esophageal cancer based on individualized risk stratification in China: Real-world evidence from the ESECC trial

Fuxiao Li,Mengfei Liu,Chuanhai Guo,Ruiping Xu,Fenglei Li,Zhen Liu,Yaqi Pan,Fangfang Liu,Ying Liu,Hong Cai,Zhonghu He,Yang Ke

DOI: https://doi.org/10.3389/fonc.2022.1002693

IF: 4.7

2022-11-30

Frontiers in Oncology

Abstract:Background Conventional universal endoscopic screening with pathology-based endoscopic re-examination for esophageal squamous cell carcinoma is in need of reform in China. We established a “two-step” precision screening strategy using two risk prediction models and have evaluated the cost-effectiveness of this precision strategy compared with the traditional strategy based on a large population-level randomized controlled trial from a healthcare provider’s perspective. Methods Four precision screening strategies with different risk cutoffs at baseline screening and endoscopic surveillance were constructed, and then compared with traditional strategy through modeling using subjects from the screening cohort of the ESECC (Endoscopic Screening for Esophageal Cancer in China) trial. Total screening costs and the number of SDA (severe dysplasia and above in lesions of the esophagus) cases were obtained to calculate the average screening cost per SDA detected, the incremental cost-effectiveness ratio (ICER) and protection rates. Sensitivity analysis was conducted to evaluate uncertainties. Results Compared to traditional strategy, all precision screening strategies have much lower average costs for detection of one SDA case ($7,148~$11,537 vs. $14,944). In addition, precision strategies 1&2 (strategies 1,2,3,4 described below) achieved higher effectiveness (143~150 vs. 136) and higher protection rates (87.7%~92.0% vs. 83.4%) at lower cost ($1,649,727~$1,672,221 vs. $2,032,386), generating negative ICERs (-$54,666/SDA~-$25,726/SDA) when compared to the traditional strategy. The optimal strategies within different willingness-to-pay (WTP) ranges were all precision screening strategies, and higher model sensitivities were adopted as WTP increased. Conclusions Precision screening strategy for esophageal cancer based on risk stratification is more cost-effective than use of traditional screening strategy and has practical implications for esophageal cancer screening programs in China.

oncology
Determining an Evidence-Based Surveillance Target and Respective Intervals for Esophageal Squamous Cell Carcinoma Following Screening: A Population-Based Cohort Study in China

Mengfei Liu,Ren Zhou,Chuanhai Guo,Ruiping Xu,Anxiang Liu,Haijun Yang,Fenglei Li,Li-Ping Duan,Lin Shen,Qi Wu,Zhen Liu,Fangfang Liu,Ying Liu,Yaqi Pan,Zhe Hu,Huanyu Bao,Hong Cai,Zhonghu He,Yang Ke

DOI: https://doi.org/10.2139/ssrn.3778696

2021-01-01

Abstract:Background: The protocol for surveillance for Esophageal Squamous Cell Carcinoma (ESCC) in China following screening lacks evidence from large-scale population-based studies. We aim to establish an evidence-based surveillance target and respective intervals for ESCC surveillance. Methods: This study enrolled 14980 subjects from a large-scale randomized controlled trial in China. Poisson regression models were applied to estimate adjusted incidence rate ratios (IRR) for subjects with Lugol-unstained lesions (LUL) of differing size and baseline pathologic diagnosis. We clustered subgroups of subjects with LULs of varying size and pathologic status into three categories (low, moderate and high risk) according to their risk of progression to ESCC. Cumulative incidence of ESCC was calculated year by year for these three categories to determine appropriate surveillance intervals. Findings: LUL size is a principal predictor of post-screening risk of ESCC besides the pathologic diagnosis (adjusted IRR 6-10 mm VS none = 8·54, 95%CI: 2·78-26·24; adjusted IRR >10 mm VS none = 30·91, 95%CI: 10·69-89·39). Subjects with LULs >10mm (irrespective of the pathologic diagnosis) had the highest risk of progression, and the risk grew rapidly after the 2 nd year following the index endoscopy. Subjects with LULs of 6-10mm (irrespective of the pathologic diagnosis) or dysplastic LULs of 1-5mm had moderate risk, and the risk started to rise after the year three. Interpretation: We propose a novel surveillance strategy for ESCC that combines Lugol’s chromoendoscopy findings and the pathologic diagnosis. Use of this strategy would improve the effectiveness of ESCC screening programs in China. Funding: This study was supported by the National Key R&D Program of China (2016YFC0901404) and the National Natural Science Foundation of China (81773501).Declaration of Interests: The authors declare that they have no competing interests.Ethics Approval Statement: Research protocols were approved by the Institutional Review Board of Peking University School of Oncology.
Initial Screening of Gastric Cancer Using Oral Contrast-Enhanced Trans-Abdominal Ultrasonography in Rural Asymptomatic Individuals.

Li Shen,Danni Zhang,Yaoping Huang,Lan Liu,Yin Zheng,Li Zhang,Dianyuan Lu,Jianrong Cai,Rongrong Zhu,Huixiang Sun,Min Shi,Yan Ni,Jun Zhang

DOI: https://doi.org/10.1016/j.canep.2022.102236

IF: 2.89

2022-01-01

Cancer Epidemiology

Abstract:Background & aims: Initial screening for high-risk population of gastric cancer (GC) is needed in rural areas of large-population countries. This study aims to explore the feasibility of applying noninvasive ultrasonography as an initial screening strategy to improve the early diagnosis and prevention of GC.Methods: Oral contrast-enhanced trans-abdominal ultrasonography (OCTU) was initially applied to screen around 15,000 residents from 24 different rural villages of Changxing Island in Shanghai, China, facilitating the iden-tification of high-risk population for further endoscopy examination. Results: 176 subjects (1.18 %) were initially identified with gastric diseases using OCTU while 14,787 ones (98.93 %) were normal with negative results. 145 out of 176 individuals (82.39 %) took further endoscopy examination, and 16 were diagnosed with GC with biopsy examination, with 9 of them at the early stage. We followed up with the Center for Disease Control and Prevention, and identified another 6 GC cases occurred within one year among OCTU-negative population, serving as an adjustment factor for sensitivity analysis. As a result, with a total of 22 GC cases included in this cohort, the positive predictive rate, the negative predictive value, sensitivity, and specificity were 9.09%, 99.96 %, 75.5 %, and 98.93 %, respectively.Conclusions: OCTU is feasible, non-invasive, low-cost, and widely acceptable in rural area, thus we proposed that OCTU is practicable to serve as a supplementary screening method to improve the early detection of GC in rural area of China and other developing countries with large population.
Observation of optical pumping effects in collinear atomic beam - laser beam(s) interaction

N. Bendali,H. Duong,J. M. S. Jalm,J. Vialie

DOI: https://doi.org/10.1051/JPHYS:019830044090101900

1983-09-01

Abstract:The detection of optical resonances by observation of the fluorescence light emitted from a fast atomic beam of Na interacting with a collinear laser beam is limited in sensitivity by optical pumping processes. In the experiment reported here, we take advantage of the optical pumping by using a second collinear laser beam, achieving then a gain in fluorescence signal. The effects of the lasers power and polarization on line shapes have been studied in the single laser excitation case as well as in the two laser beams one Mise a profit de la sensibilite de la methode de detection des resonances optiques par observation de la fluorescence emise par un faisceau rapide en excitation colineaire, limitee par le pompage optique, a l'aide d'un second laser colineaire realisant ainsi un gain sensible en signal de fluorescence. Etude des effets de la polarisation et de la puissance des faisceaux laser, dans le cas de l'excitation d'atomes Na pour un ou deux lasers
A Suggested Framework for Conducting Esophageal Cancer Screening in China

Yuan,Ling Bin Du,Xiao Qian Hu,Sanjay Jaiswal,Shu Yan Gu,Yu Xuan Gu,Heng Jin Dong

DOI: https://doi.org/10.1111/1751-2980.12675

2018-01-01

Journal of Digestive Diseases

Abstract:Esophageal cancer is one of the most prevalent malignant tumors worldwide. Because of its challenging clinical characteristics, esophageal cancer is a major disease burden on the economy, society, and individuals. There is an urgent need to establish a beneficial policy to reduce the burden and to improve the health-related quality of life of patients. Primary prevention with smoking cessation and reduction of drinking alcohol are highly recommended. Screening, early diagnosis and treatment are suggested. This study intended to establish a modified future screening model from the social perspective that deploys different strategies for different populations. Risk assessment and community-based screening are proposed for high-risk populations. Health education in low-risk areas could help promote primary prevention to mitigate lifestyle factors and to increase public awareness and potentially to increase screening and early detection.

The effect of increased positive radial acceleration upon perceptual speed ability.

Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in China.

Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized Trial

Effectiveness of Intensive Endoscopic Screening for Esophageal Cancer in China: A Community-Based Study

Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study

An initial screening strategy based on epidemiologic information in esophageal cancer screening: a prospective evaluation in a community-based cancer screening cohort in rural China

Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial

Modeling the Cost-effectiveness of Esophageal Cancer Screening in China

[Cost-Effectiveness Analysis of Esophageal Cancer Once-in-a-lifetime Endoscopic Screening in High-Risk Areas of Rural China].

Massive Endoscopic Screening for Esophageal and Gastric Cancers in a High-Risk Area of China

Beneficial Effects of Endoscopic Screening on Gastric Cancer and Optimal Screening Interval: a Population-Based Study.

Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled Trial

PP64 Economic Evaluation for Esophageal Cancer Screening in China

Effectiveness of Risk-Adapted Upper Gastrointestinal Cancer Screening in China: Prospective Cohort Study

Correction: Effectiveness of Risk-Adapted Upper Gastrointestinal Cancer Screening in China: Prospective Cohort Study

Optimal starting age of endoscopic screening for esophageal cancer in China: A multicenter prospective cohort study

Cost-effectiveness of precision screening for esophageal cancer based on individualized risk stratification in China: Real-world evidence from the ESECC trial

Determining an Evidence-Based Surveillance Target and Respective Intervals for Esophageal Squamous Cell Carcinoma Following Screening: A Population-Based Cohort Study in China

Initial Screening of Gastric Cancer Using Oral Contrast-Enhanced Trans-Abdominal Ultrasonography in Rural Asymptomatic Individuals.

Observation of optical pumping effects in collinear atomic beam - laser beam(s) interaction

A Suggested Framework for Conducting Esophageal Cancer Screening in China